Rankings
▼
Calendar
LUNG Q1 2021 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena
LUNG
Pulmonx Corporation
$75M
Q1 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$9M
+7.3% YoY
Gross Profit
$7M
71.5% margin
Operating Income
-$12M
-135.2% margin
Net Income
-$13M
-135.4% margin
EPS (Diluted)
$-0.34
QoQ Revenue Growth
-6.0%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$255M
Total Liabilities
$39M
Stockholders' Equity
$217M
Cash & Equivalents
$210M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$9M
+7.3%
Gross Profit
$7M
$6M
+17.0%
Operating Income
-$12M
-$6M
-104.7%
Net Income
-$13M
-$7M
-74.7%
Geographic Segments
UNITED STATES
$4M
46%
EMEA
$4M
44%
Asia Pacific
$911,000
10%
← FY 2021
All Quarters
Q2 2021 →